Track topics on Twitter Track topics that are important to you
A new rheumatoid arthritis JAK inhibitor called peficitinib has fared well in new trials, scientists outline in Annals of the Rheumatic Diseases. A total of 507 people with rheumatoid arthritis and an inadequate response to disease-modifying anti-rheumatic drugs (DMARDs) were split into groups for 52 weeks: peficitinib 100mg once daily; peficitinib 150mg once daily; placebo […]
The post Peficitinib reduces rheumatoid arthritis symptoms in latest trial appeared first on Arthritis Digest.
Original Article: Peficitinib reduces rheumatoid arthritis symptoms in latest trialNEXT ARTICLE
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...